Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan

Background: Since 2011, Taiwan’s National Health Insurance Administration (NHIA) issued a regulation on the reimbursement to anti-osteoporosis medications (AOMs). This study aimed to evaluate the impact of this regulation in reimbursement on the utilization of AOMs, clinical outcomes and associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chen-Yu, Fu, Shau-Huai, Hung, Chih-Chien, Yang, Rong-Sen, Lin, Jou-Wei, Chen, Ho-Min, Hsiao, Fei-Yuan, Shen, Li-Jiuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309953/
https://www.ncbi.nlm.nih.gov/pubmed/33059424
http://dx.doi.org/10.34172/ijhpm.2020.169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309953/
https://www.ncbi.nlm.nih.gov/pubmed/33059424
http://dx.doi.org/10.34172/ijhpm.2020.169

Ejemplares similares